Table 3

Summary of recurrence-free survival (RFS) for 69 patients with high-grade TCC.

RFS All Patients Ag Negative Patients Ag Positive Patients
Median RFS (95% CI) 24.4 mo (15.8, 70.2) 24.4 mo (17.9, 70.2) Not reached
One-year RFS (95% CI) 68% (57, 79) 69% (54, 85) 67% (50, 83)
Two-year RFS (95% CI) 51% (38, 64) 51% (33, 69) 52% (34, 70)